Product Information

BUSPIRONE HCL 15 MG TABLET is a generic product labeled by AvPAK, priced at $0.0423 per EA under NDC 50268013515. Its NADAC has been published 268 times since May 12, 2021.

The Low Outlier badge above means this manufacturer's average price in the Buspirone hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BUSPIRONE HCL 15 MG TABLET

Buspirone hydrochloride
$0.0423per EA
Low Outlier

Strength

15 mg/1

Manufacturer

AvPAK

NDC

50268013515

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078888

On Market Since

10/21/2020

Price Statistics

The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 268 times since May 12, 2021, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0423 per EA
All-time high$0.0605 (May 12, 2021)
All-time low$0.0359 (Nov 20, 2024)
52-week high$0.0485
52-week low$0.0423
Median price$0.0484
Average price$0.0485
Largest weekly change-29.4% (Nov 20, 2024)
Weeks tracked268
Tracking sinceMay 12, 2021

Price History

1W

0.0%

1M

-1.5%

3M

-2.5%

6M

-11.9%

1Y

-9.1%

3Y

-17.4%

5Y

-22.0%

All

-30.1%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by AvPAK, is $0.0423 per EA (NDC 50268013515), effective Jun 24, 2026.

How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 30.1%. It has been tracked across 268 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?

Since May 12, 2021, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0605 (May 12, 2021), with a median of $0.0484 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?

4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 15 MG TABLET, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 15 MG TABLET?

BUSPIRONE HCL 15 MG TABLET (NDC 50268013515) is labeled by AvPAK, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.